Regional Focus Hatteras VPs leadership role in North Carolina and the Southeastern United States suggests a strong regional network and deal flow potential for regional life sciences vendors, CROs, and lab infrastructure providers seeking to partner with a reputable sponsor.

Portfolio Growth With over 100 portfolio companies and multiple late-stage financings (Series A/B) across biotech, medtech, and healthtech, there are ongoing collaboration opportunities for strategic exits, co-investments, and secondaries through Hatteras’ active deal participation.

Science to Market A focus on translating leading academic science into commercial ventures indicates appetite for technology transfer, clinical collaboration, regulatory strategy consulting, and translational research partnerships.

Investment Capacity Managing over $900 million across seven core funds and a demonstrated track record of leading significant rounds signals readiness for growth-stage partnerships, equity financing services, and value-add support for portfolio companies.

Strategic Synergies Active involvement in biotech councils and regional biotech ecosystems, plus experience with AI-enabled therapeutics and digital health, presents opportunities for strategic partnerships with service providers, platforms, or tools that enhance diligence, portfolio value, and go-to-market acceleration.